ABBV vs LH
By Alex · Tickerpine
AbbVie Inc. vs Labcorp Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | LH |
|---|---|---|
| Price | $248.76 | $323.48 |
| Market cap | $439.59B | $26.23B |
| P/E ratio | 70.5 | 26.7 |
| ROE | — | 11.73% |
| Profit margin | 9.80% | 6.99% |
| Revenue growth | 10.20% | 5.80% |
| Dividend yield | 2.77% | 0.89% |
| Beta | 0.28 | 0.84 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs LH in plain English
- ABBV is the bigger company — about 16.8× the market cap of LH.
- LH is cheaper on earnings (P/E 26.7 vs 70.5).
- ABBV is growing revenue faster (10% vs 6%).
- ABBV has the higher dividend yield (2.77% vs 0.89%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
LH return calculator
See what $1,000 in Labcorp Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.